Hereditary cystatin C (gamma-trace) amyloid angiopathy of the CNS causing cerebral hemorrhage

O Jensson, G Gudmundsson, A Arnason, H Blöndal, I Petursdottir, L Thorsteinsson, A Grubb, H Löfberg, D Cohen, B Frangione

Research output: Contribution to journalArticlepeer-review


Hereditary CNS amyloid angiopathy occurring in Icelanders is the first human disorder known to be caused by deposition of cystatin C amyloid fibrils in the walls of the brain arteries leading to single or or multiple strokes with fatal outcome. One or more affected members have been verified by histological examination in 8 families containing 127 affected. These originated from the same geographic area. Abnormally low value of cystatin C found in the cerebrospinal fluid of those affected can be used to support or make diagnosis of this disease, also in asymptomatic relatives. By amino acid sequence analysis the amyloid fibrils in the patients are found to be a variant of cystatin C (gamma-trace), a major cysteine proteinase inhibitor. The variant protein has an amino acid substitution (glutamine for leucine) at position 58 in the amyloid molecule. It is postulated that a point mutation has occurred leading to production of amyloidogenic protein causing the disorder.

Original languageEnglish
Pages (from-to)102-114
JournalActa Neurologica Scandinavica
Issue number2
Publication statusPublished - 1987

Subject classification (UKÄ)

  • Pharmacology and Toxicology
  • Medicinal Chemistry


  • Amyloid/metabolism
  • Amyloidosis/genetics
  • Brain/pathology
  • Cerebral Hemorrhage/genetics
  • Cerebrovascular Disorders/genetics
  • Cystatin C
  • Cystatins
  • Female
  • Humans
  • Iceland
  • Male
  • Pedigree
  • Proteins/metabolism


Dive into the research topics of 'Hereditary cystatin C (gamma-trace) amyloid angiopathy of the CNS causing cerebral hemorrhage'. Together they form a unique fingerprint.

Cite this